JPRN-UMIN000005068已完成未知
The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients - The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients
Yamamoto General Hospital0 个研究点目标入组 20 人开始时间: 2011年2月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •severe heart failure impossible control of hypertension and so on
研究者
相似试验
已完成
不适用
Darbepoetin alpha for anemia in patients with chronic hepatitis C treated with combination therapy of peginterferon alpha-2b plus ribaviriChronic hepatitis CJPRN-UMIN000004141Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences21
招募中
2 期
ITHRIVE: Iron and erythropoietin use in anaemic patients in the intensive careAnaemiaCritical IllnessBlood - AnaemiaACTRN12621000595819Fiona Stanley Hospital550
已完成
不适用
Effect of daprodustat on renal anemia in patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000041546Saitama Tsukinomori Clinic10
已完成
2 期
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic SyndromeMyelodysplastic SyndromesNCT00095264Amgen209
已完成
不适用
Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal AnemiaPeritoneal Dialysis, Continuous AmbulatoryAnemiaKidney Failure, ChronicNCT00563446Hospital Authority, Hong Kong16